{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:14Z","timestamp":1777984334630,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Health Commission Science and Technology Projects","award":["TJWJ2021QN061 and ZC20134"],"award-info":[{"award-number":["TJWJ2021QN061 and ZC20134"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["No. TJYXZDXK-052B"],"award-info":[{"award-number":["No. TJYXZDXK-052B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04671-5","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T23:15:13Z","timestamp":1771283713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of serum complement C3 in blood\u2013brain barrier injury and prognosis of anti-NMDAR encephalitis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jinwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"4671_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s1474-4422(10)70253-2","volume":"10 1","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10 1:63\u201374. https:\/\/doi.org\/10.1016\/s1474-4422(10)70253-2.","journal-title":"Lancet Neurol"},{"key":"4671_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/s1473-3099(10)70222-x","volume":"10 12","author":"J Granerod","year":"2010","unstructured":"Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in england: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10 12:835\u201344. https:\/\/doi.org\/10.1016\/s1473-3099(10)70222-x.","journal-title":"Lancet Infect Dis"},{"key":"4671_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1743-422x-5-134","volume":"5","author":"F Jmor","year":"2008","unstructured":"Jmor F, Emsley HC, Fischer M, Solomon T, Lewthwaite P. The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virol J. 2008;5:134. https:\/\/doi.org\/10.1186\/1743-422x-5-134.","journal-title":"Virol J"},{"key":"4671_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"D Josep","year":"2018","unstructured":"Josep D, Francesc G, Antibody-Mediated Encephalitis. N Engl J Med. 2018;378:9. https:\/\/doi.org\/10.1056\/NEJMra1708712.","journal-title":"N Engl J Med"},{"key":"4671_CR5","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1007\/s10571-023-01371-3","volume":"43 7","author":"Z Gong","year":"2023","unstructured":"Gong Z, Lao D, Wu Y, Li T, Lv S, Mo X, et al. Inhibiting PI3K\/Akt-Signaling pathway improves neurobehavior changes in Anti-NMDAR encephalitis mice by ameliorating Blood-Brain barrier disruption and neuronal damage. Cell Mol Neurobiol. 2023;43 7:3623\u201337. https:\/\/doi.org\/10.1007\/s10571-023-01371-3.","journal-title":"Cell Mol Neurobiol"},{"key":"4671_CR6","doi-asserted-by":"publisher","unstructured":"J\u00e9z\u00e9quel J, Johansson EM, Dupuis JP, Rogemond V, Gr\u00e9a H, Kellermayer B, et al. Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients. Nat Commun. 2017;8(1:1791). https:\/\/doi.org\/10.1038\/s41467-017-01700-3.","DOI":"10.1038\/s41467-017-01700-3"},{"key":"4671_CR7","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.jaut.2019.102339","volume":"104","author":"H Alexopoulos","year":"2019","unstructured":"Alexopoulos H, Dalakas MC. The immunobiology of autoimmune encephalitides. J Autoimmun. 2019;104:102339. https:\/\/doi.org\/10.1016\/j.jaut.2019.102339.","journal-title":"J Autoimmun"},{"key":"4671_CR8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s1474-4422(08)70224-2","volume":"7 12","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7 12:1091\u20138. https:\/\/doi.org\/10.1016\/s1474-4422(08)70224-2.","journal-title":"Lancet Neurol"},{"key":"4671_CR9","doi-asserted-by":"publisher","unstructured":"Jingxiao Z, Yatong L, Lei L, Feifei D, Yujing P, Qiuying M, et al. Development of a short-term prognostic model for anti-N-methyl-D-aspartate receptor encephalitis in Chinese patients. BMC Neurol. 2024;24(1). https:\/\/doi.org\/10.1186\/s12883-024-03724-x.","DOI":"10.1186\/s12883-024-03724-x"},{"key":"4671_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1089\/neu.2019.6942","volume":"37 5","author":"M Chen","year":"2020","unstructured":"Chen M, Edwards SR, Reutens DC. Complement in the development of Post-Traumatic epilepsy: prospects for drug repurposing. J Neurotrauma. 2020;37 5:692\u2013705. https:\/\/doi.org\/10.1089\/neu.2019.6942.","journal-title":"J Neurotrauma"},{"key":"4671_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ijms22094675","volume":"22","author":"K Ziabska","year":"2021","unstructured":"Ziabska K, Ziemka-Nalecz M, Pawelec P, Sypecka J, Zalewska T. Aberrant complement system activation in neurological disorders. Int J Mol Sci. 2021;22:9. https:\/\/doi.org\/10.3390\/ijms22094675.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4671_CR12","doi-asserted-by":"publisher","first-page":"e0122048","DOI":"10.1371\/journal.pone.0122048","volume":"10","author":"S Aeinehband","year":"2015","unstructured":"Aeinehband S, Lindblom RP, Al Nimer F, Vijayaraghavan S, Sandholm K, Khademi M, et al. Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis. PLoS ONE. 2015;10(4):e0122048. https:\/\/doi.org\/10.1371\/journal.pone.0122048.","journal-title":"PLoS ONE"},{"key":"4671_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/ana.26226","volume":"90 6","author":"CW Keller","year":"2021","unstructured":"Keller CW, Lopez JA, Wendel EM, Ramanathan S, Gross CC, Klotz L, et al. Complement activation is a prominent feature of MOGAD. Ann Neurol. 2021;90 6:976\u201382. https:\/\/doi.org\/10.1002\/ana.26226.","journal-title":"Ann Neurol"},{"key":"4671_CR14","doi-asserted-by":"publisher","first-page":"853891","DOI":"10.3389\/fimmu.2022.853891","volume":"13","author":"L Lin","year":"2022","unstructured":"Lin L, Wu Y, Hang H, Lu J, Ding Y. Plasma complement 3 and complement 4 are promising biomarkers for distinguishing NMOSD from MOGAD and are associated with the Blood-Brain-Barrier disruption in NMOSD. Front Immunol. 2022;13:853891. https:\/\/doi.org\/10.3389\/fimmu.2022.853891.","journal-title":"Front Immunol"},{"key":"4671_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/1744666x.2022.2105205","volume":"18 9","author":"P Stathopoulos","year":"2022","unstructured":"Stathopoulos P, Dalakas MC. The role of complement and complement therapeutics in neuromyelitis Optica spectrum disorders. Expert Rev Clin Immunol. 2022;18 9:933\u201345. https:\/\/doi.org\/10.1080\/1744666x.2022.2105205.","journal-title":"Expert Rev Clin Immunol"},{"key":"4671_CR16","doi-asserted-by":"publisher","first-page":"120512","DOI":"10.1016\/j.jns.2022.120512","volume":"444","author":"YG Min","year":"2023","unstructured":"Min YG, Ju W, Seo JW, Ha YE, Ban JJ, Kwon YN, et al. Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barr\u00e9 syndrome. J Neurol Sci. 2023;444:120512. https:\/\/doi.org\/10.1016\/j.jns.2022.120512.","journal-title":"J Neurol Sci"},{"key":"4671_CR17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/1744666x.2022.2082946","volume":"18 7","author":"MC Dalakas","year":"2022","unstructured":"Dalakas MC. Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia Gravis. Expert Rev Clin Immunol. 2022;18 7:691\u2013701. https:\/\/doi.org\/10.1080\/1744666x.2022.2082946.","journal-title":"Expert Rev Clin Immunol"},{"key":"4671_CR18","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/ene.15730","volume":"30 5","author":"F Stascheit","year":"2023","unstructured":"Stascheit F, Chuquisana O, Keller CW, Ambrose PA, Hoffmann S, Gross CC, et al. Complement activation profiles in anti-acetylcholine receptor positive myasthenia Gravis. Eur J Neurol. 2023;30 5:1409\u201316. https:\/\/doi.org\/10.1111\/ene.15730.","journal-title":"Eur J Neurol"},{"issue":"1","key":"4671_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/ene.13495","volume":"25","author":"Y Shu","year":"2018","unstructured":"Shu Y, Chen C, Chen Y, Xu Y, Chang Y, Li R, et al. Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis. Eur J Neurol. 2018;25(1):178\u201384. https:\/\/doi.org\/10.1111\/ene.13495.","journal-title":"Eur J Neurol"},{"key":"4671_CR20","doi-asserted-by":"publisher","first-page":"840003","DOI":"10.3389\/fimmu.2022.840003","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Fan K, Lin Q, Tang M, Wang Q, Huang E, et al. Serum-Derived Exosomal miR-140-5p as a promising biomarker for differential diagnosis of Anti-NMDAR encephalitis with viral encephalitis. Front Immunol. 2022;13:840003. https:\/\/doi.org\/10.3389\/fimmu.2022.840003.","journal-title":"Front Immunol"},{"key":"4671_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s1474-4422(15)00401-9","volume":"15 4","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15 4:391\u2013404. https:\/\/doi.org\/10.1016\/s1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"key":"4671_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.str.19.5.604","volume":"19 5","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19 5:604\u20137. https:\/\/doi.org\/10.1161\/01.str.19.5.604.","journal-title":"Stroke"},{"key":"4671_CR23","doi-asserted-by":"publisher","first-page":"e2204","DOI":"10.1212\/wnl.0000000000207221","volume":"100 21","author":"J Brenner","year":"2023","unstructured":"Brenner J, Mariotto S, Bastiaansen AEM, Paunovic M, Ferrari S, Alberti D, et al. Predictive value of serum neurofilament light chain levels in Anti-NMDA receptor encephalitis. Neurology. 2023;100 21:e2204\u201313. https:\/\/doi.org\/10.1212\/wnl.0000000000207221.","journal-title":"Neurology"},{"key":"4671_CR24","doi-asserted-by":"publisher","unstructured":"Xu X, Lu Q, Huang Y, Fan S, Zhou L, Yuan J, et al. Anti-NMDAR encephalitis: A single-center, longitudinal study in China. Neurol Neuroimmunol Neuroinflamm. 2020;7(1). https:\/\/doi.org\/10.1212\/nxi.0000000000000633.","DOI":"10.1212\/nxi.0000000000000633"},{"key":"4671_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1474-4422(12)70310-1","volume":"12 2","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12 2:157\u201365. https:\/\/doi.org\/10.1016\/s1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"key":"4671_CR26","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/brain\/aww208","volume":"139","author":"J Kreye","year":"2016","unstructured":"Kreye J, Wenke NK, Chayka M, Leubner J, Murugan R, Maier N, et al. Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain. 2016;139:2641\u201352. https:\/\/doi.org\/10.1093\/brain\/aww208.","journal-title":"Brain"},{"issue":"1","key":"4671_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166\u201377. https:\/\/doi.org\/10.1002\/ana.25131.","journal-title":"Ann Neurol"},{"key":"4671_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s1474-4422(18)30244-8","volume":"17 9","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A, Mattozzi S, C\u00e1rceles-Cordon M, Martinez-Heras E, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17 9:760\u201372. https:\/\/doi.org\/10.1016\/s1474-4422(18)30244-8.","journal-title":"Lancet Neurol"},{"key":"4671_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/nejm200104053441406","volume":"344 14","author":"MJ Walport","year":"2001","unstructured":"Walport MJ, Complement. First of two parts. N Engl J Med. 2001;344 14:1058\u201366. https:\/\/doi.org\/10.1056\/nejm200104053441406.","journal-title":"N Engl J Med"},{"key":"4671_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00277-016-2863-z","volume":"96 2","author":"F Jiang","year":"2017","unstructured":"Jiang F, Liu H, Liu Z, Song J, Li L, Ding K, et al. High serum levels of complements C3 and C4 as novel markers for myeloma bone disease. Ann Hematol. 2017;96 2:331\u20133. https:\/\/doi.org\/10.1007\/s00277-016-2863-z.","journal-title":"Ann Hematol"},{"issue":"8\u20139","key":"4671_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0145-305X(01)00034-9","volume":"25","author":"IK Zarkadis","year":"2001","unstructured":"Zarkadis IK, Mastellos D, Lambris JD. Phylogenetic aspects of the complement system. Dev Comp Immunol. 2001;25(8\u20139):745\u201362. https:\/\/doi.org\/10.1016\/s0145-305x(01)00034-9","journal-title":"Dev Comp Immunol"},{"key":"4671_CR32","doi-asserted-by":"publisher","first-page":"1396520","DOI":"10.3389\/fneur.2024.1396520","volume":"15","author":"L Negro-Demontel","year":"2024","unstructured":"Negro-Demontel L, Maleki AF, Reich DS, Kemper C. The complement system in neurodegenerative and inflammatory diseases of the central nervous system. Front Neurol. 2024;15:1396520. https:\/\/doi.org\/10.3389\/fneur.2024.1396520.","journal-title":"Front Neurol"},{"key":"4671_CR33","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/14712598.2021.1884223","volume":"21 8","author":"N Asavapanumas","year":"2021","unstructured":"Asavapanumas N, Tradtrantip L, Verkman AS. Targeting the complement system in neuromyelitis Optica spectrum disorder. Expert Opin Biol Ther. 2021;21 8:1073\u201386. https:\/\/doi.org\/10.1080\/14712598.2021.1884223.","journal-title":"Expert Opin Biol Ther"},{"key":"4671_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fimmu.2019.00362","volume":"10","author":"SM Carpanini","year":"2019","unstructured":"Carpanini SM, Torvell M, Morgan BP. Therapeutic Inhibition of the complement system in diseases of the central nervous system. Front Immunol. 2019;10:362. https:\/\/doi.org\/10.3389\/fimmu.2019.00362.","journal-title":"Front Immunol"},{"key":"4671_CR35","doi-asserted-by":"publisher","first-page":"e200270","DOI":"10.1212\/nxi.0000000000200270","volume":"11 4","author":"JD Lunemann","year":"2024","unstructured":"Lunemann JD, Hegen H, Villar LM, Rejdak K, Sao-Aviles A, Carbonell-Mirabent P, et al. Association of complement factors with disability progression in primary progressive multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2024;11 4:e200270. https:\/\/doi.org\/10.1212\/nxi.0000000000200270.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4671_CR36","doi-asserted-by":"publisher","first-page":"e200212","DOI":"10.1212\/nxi.0000000000200212","volume":"11 2","author":"J Oechtering","year":"2024","unstructured":"Oechtering J, Stein K, Schaedelin SA, Maceski AM, Orleth A, Meier S, et al. Complement activation is associated with disease severity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2024;11 2:e200212. https:\/\/doi.org\/10.1212\/nxi.0000000000200212.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4671_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","volume":"77 6","author":"E Martinez-Hernandez","year":"2011","unstructured":"Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology. 2011;77 6:589\u201393. https:\/\/doi.org\/10.1212\/WNL.0b013e318228c136.","journal-title":"Neurology"},{"key":"4671_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/1352458508099139","volume":"15 3","author":"H Doi","year":"2009","unstructured":"Doi H, Matsushita T, Isobe N, Matsuoka T, Minohara M, Ochi H, et al. Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody. Mult Scler. 2009;15 3:304\u201310. https:\/\/doi.org\/10.1177\/1352458508099139.","journal-title":"Mult Scler"},{"key":"4671_CR39","doi-asserted-by":"publisher","first-page":"18713","DOI":"10.1038\/srep18713","volume":"6","author":"Z Liu","year":"2016","unstructured":"Liu Z, Tang Q, Wen J, Tang Y, Huang D, Huang Y, et al. Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study. Sci Rep. 2016;6:18713. https:\/\/doi.org\/10.1038\/srep18713.","journal-title":"Sci Rep"},{"key":"4671_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","volume":"139 5","author":"R H\u00f6ftberger","year":"2020","unstructured":"H\u00f6ftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, et al. The pathology of central nervous system inflammatory demyelinating disease accompanying Myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020;139 5:875\u201392. https:\/\/doi.org\/10.1007\/s00401-020-02132-y.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"4671_CR41","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain. 2002;125(7):1450\u201361. https:\/\/doi.org\/10.1093\/brain\/awf151","journal-title":"Brain"},{"key":"4671_CR42","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","volume":"135","author":"CG Bien","year":"2012","unstructured":"Bien CG, Vincent A, Barnett MH, Becker AJ, Bl\u00fcmcke I, Graus F, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135:1622\u201338. https:\/\/doi.org\/10.1093\/brain\/aws082.","journal-title":"Brain"},{"key":"4671_CR43","doi-asserted-by":"publisher","unstructured":"Shu Y, Peng F, Zhao B, Liu C, Li Q, Li H, et al. Transfer of patient\u2019s peripheral blood mononuclear cells (PBMCs) disrupts blood-brain barrier and induces anti-NMDAR encephalitis: a study of novel humanized PBMC mouse model. J Neuroinflammation. 2023;20(1:164). https:\/\/doi.org\/10.1186\/s12974-023-02844-4.","DOI":"10.1186\/s12974-023-02844-4"},{"key":"4671_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molimm.2018.06.267","volume":"102","author":"JJ Alexander","year":"2018","unstructured":"Alexander JJ. Blood-brain barrier (BBB) and the complement landscape. Mol Immunol. 2018;102:26\u201331. https:\/\/doi.org\/10.1016\/j.molimm.2018.06.267.","journal-title":"Mol Immunol"},{"key":"4671_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/156720511794604589","volume":"8 1","author":"R Veerhuis","year":"2011","unstructured":"Veerhuis R. Histological and direct evidence for the role of complement in the neuroinflammation of AD. Curr Alzheimer Res. 2011;8 1:34\u201358. https:\/\/doi.org\/10.2174\/156720511794604589.","journal-title":"Curr Alzheimer Res"},{"key":"4671_CR46","doi-asserted-by":"publisher","first-page":"102654","DOI":"10.1016\/j.pneurobio.2024.102654","volume":"240","author":"F Zhu","year":"2024","unstructured":"Zhu F, He P, Jiang W, Afridi SK, Xu H, Alahmad M, et al. Astrocyte-secreted C3 signaling impairs neuronal development and cognition in autoimmune diseases. Prog Neurobiol. 2024;240:102654. https:\/\/doi.org\/10.1016\/j.pneurobio.2024.102654.","journal-title":"Prog Neurobiol"},{"key":"4671_CR47","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.ymthe.2023.07.017","volume":"31 9","author":"L Xu","year":"2023","unstructured":"Xu L, Xu H, Chen S, Jiang W, Afridi SK, Wang Y, et al. Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases. Mol Ther. 2023;31 9:2715\u201333. https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.017.","journal-title":"Mol Ther"},{"key":"4671_CR48","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1172\/jci134816","volume":"130 8","author":"T Chen","year":"2020","unstructured":"Chen T, Lennon VA, Liu YU, Bosco DB, Li Y, Yi MH, et al. Astrocyte-microglia interaction drives evolving neuromyelitis Optica lesion. J Clin Invest. 2020;130 8:4025\u201338. https:\/\/doi.org\/10.1172\/jci134816.","journal-title":"J Clin Invest"},{"key":"4671_CR49","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3389\/fimmu.2018.01753","volume":"9","author":"ML Dubbelaar","year":"2018","unstructured":"Dubbelaar ML, Kracht L, Eggen BJL, Boddeke E. The kaleidoscope of microglial phenotypes. Front Immunol. 2018;9:1753. https:\/\/doi.org\/10.3389\/fimmu.2018.01753.","journal-title":"Front Immunol"},{"key":"4671_CR50","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/brain\/awab102","volume":"144 8","author":"Y Takai","year":"2021","unstructured":"Takai Y, Misu T, Suzuki H, Takahashi T, Okada H, Tanaka S, et al. Staging of astrocytopathy and complement activation in neuromyelitis Optica spectrum disorders. Brain. 2021;144 8:2401\u201315. https:\/\/doi.org\/10.1093\/brain\/awab102.","journal-title":"Brain"},{"key":"4671_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12974-016-0485-y","volume":"13","author":"F Wu","year":"2016","unstructured":"Wu F, Zou Q, Ding X, Shi D, Zhu X, Hu W, et al. Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain. J Neuroinflammation. 2016;13:23. https:\/\/doi.org\/10.1186\/s12974-016-0485-y.","journal-title":"J Neuroinflammation"},{"key":"4671_CR52","doi-asserted-by":"publisher","unstructured":"Luan Victor Resque R, Marcela MBM et al. Bruno Marcel Silva dM, Jos\u00e9 Teles dON, Evellin Karina Pires B, Jos\u00e9 Carlos Farias Alves F,. Antagonism of the complement receptor reduces oxidative stress and matrix metalloproteinase (MMP)-2 activity in the aortas of mice with angiotensin-II-induced hypertension. Vascul Pharmacol. 2025;160 0; https:\/\/doi.org\/10.1016\/j.vph.2025.107523","DOI":"10.1016\/j.vph.2025.107523"},{"key":"4671_CR53","doi-asserted-by":"publisher","unstructured":"Walter SS, Stefan PK, Randolph H, Katharina MK, Christoph K, Gerhard B, et al. The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro. FASEB J. 2010;25(1). https:\/\/doi.org\/10.1096\/fj.10-156083.","DOI":"10.1096\/fj.10-156083"},{"key":"4671_CR54","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s13311-021-01178-4","volume":"19 3","author":"I Smets","year":"2022","unstructured":"Smets I, Titulaer MJ. Antibody therapies in autoimmune encephalitis. Neurotherapeutics. 2022;19 3:823\u201331. https:\/\/doi.org\/10.1007\/s13311-021-01178-4.","journal-title":"Neurotherapeutics"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04671-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:30:10Z","timestamp":1774434610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4671"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04671-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7220180\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study followed the Declaration of Helsinki and was approved by the Ethics Committee of Tianjin Huanhu Hospital (202410281325000227905). Written informed consent to participate in this study was provided by the participants\u2019 legal guardian\/next of kin. Written informed consent was obtained from the individual(s), and minor(s)\u2019 legal guardian\/next of kin, for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}